[Taylor&Francis] Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran

goodbadbird Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-28 20:22
Reward30points

journalㄩExpert Review of Pharmacoeconomics & Outcomes Research

AuthorsㄩNegin Bashari; Majid Safaei Lari; Ali Darvishi; Rajabali Daroudi

Published dateㄩ2024-2-7

DOIㄩ10.1080/14737167.2023.2263164

PDF linkㄩhttps://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2263164

Article linkㄩhttps://doi.org/10.1080/14737167.2023.2263164

Article SourceㄩInforma UK Limited


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
tgt Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list